Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications
Top Cited Papers
- 30 January 2006
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 78 (18) , 2073-2080
- https://doi.org/10.1016/j.lfs.2005.12.006
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interactionInternational Journal of Cardiology, 2005
- Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-GallateClinical Cancer Research, 2004
- Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null MiceCirculation, 2004
- Green Tea Protection Against Age-Dependent Ethanol-Induced Oxidative StressJournal of Toxicology and Environmental Health, Part A, 2004
- Aging and oxidative stressMolecular Aspects of Medicine, 2004
- Inhibition of Carcinogenesis by TeaAnnual Review of Pharmacology and Toxicology, 2002
- The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neuronsLife Sciences, 2001
- Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radicalPublished by Elsevier ,1999
- Preclinical Efficacy Studies of Green and Black Tea ExtractsProceedings of the Society for Experimental Biology and Medicine, 1999
- Screening of anticarcinogenic ingredients in tea polyphenolsCancer Letters, 1997